Published in Br J Pharmacol on June 01, 2010
Measurement of plasma hydrogen sulfide in vivo and in vitro. Free Radic Biol Med (2011) 1.74
Hydrogen sulphide and angiogenesis: mechanisms and applications. Br J Pharmacol (2011) 1.63
A practical look at the chemistry and biology of hydrogen sulfide. Antioxid Redox Signal (2012) 1.60
Hydrogen sulfide chemical biology: pathophysiological roles and detection. Nitric Oxide (2013) 1.56
Hydrogen sulfide is a signaling molecule and a cytoprotectant. Antioxid Redox Signal (2012) 1.55
Inhaled hydrogen sulfide prevents endotoxin-induced systemic inflammation and improves survival by altering sulfide metabolism in mice. Antioxid Redox Signal (2012) 1.42
Analytical measurement of discrete hydrogen sulfide pools in biological specimens. Free Radic Biol Med (2012) 1.37
Hydrogen sulfide anion regulates redox signaling via electrophile sulfhydration. Nat Chem Biol (2012) 1.32
Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part I. Biochemical and physiological mechanisms. Br J Pharmacol (2014) 1.30
Chemical probes for molecular imaging and detection of hydrogen sulfide and reactive sulfur species in biological systems. Chem Soc Rev (2015) 1.25
Roles of hydrogen sulfide in the pathogenesis of diabetes mellitus and its complications. Antioxid Redox Signal (2012) 1.21
Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimeras. Biochem Pharmacol (2012) 1.19
H2S concentrations in the arterial blood during H2S administration in relation to its toxicity and effects on breathing. Am J Physiol Regul Integr Comp Physiol (2013) 1.19
Gaseotransmitters: new frontiers for translational science. Sci Transl Med (2010) 1.18
The therapeutic potential of cystathionine β-synthetase/hydrogen sulfide inhibition in cancer. Antioxid Redox Signal (2014) 1.17
Hydrogen sulfide preconditions the db/db diabetic mouse heart against ischemia-reperfusion injury by activating Nrf2 signaling in an Erk-dependent manner. Am J Physiol Heart Circ Physiol (2013) 1.16
Oxygen deficit and H2S in hemorrhagic shock in rats. Crit Care (2012) 1.13
Chemical foundations of hydrogen sulfide biology. Nitric Oxide (2013) 1.11
Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part II. Pathophysiological and therapeutic aspects. Br J Pharmacol (2014) 1.10
Signaling molecules: hydrogen sulfide and polysulfide. Antioxid Redox Signal (2014) 1.07
Hydrogen sulfide inhibits the renal fibrosis of obstructive nephropathy. Kidney Int (2013) 1.05
Cystathionine γ-lyase deficiency protects mice from galactosamine/lipopolysaccharide-induced acute liver failure. Antioxid Redox Signal (2013) 1.00
Pharmacological tools for hydrogen sulphide research: a brief, introductory guide for beginners. Br J Pharmacol (2014) 0.98
In vivo interactions between cobalt or ferric compounds and the pools of sulphide in the blood during and after H2S poisoning. Toxicol Sci (2014) 0.94
Long-term release of a thiobenzamide from a backbone functionalized poly(lactic acid). Polym Chem (2015) 0.89
Endogenous H2S in hemorrhagic shock: innocent bystander or central player? Crit Care (2012) 0.89
The role of H2S bioavailability in endothelial dysfunction. Trends Pharmacol Sci (2015) 0.88
Development of selective colorimetric probes for hydrogen sulfide based on nucleophilic aromatic substitution. J Org Chem (2013) 0.88
Plasma free H2S levels are elevated in patients with cardiovascular disease. J Am Heart Assoc (2013) 0.87
Mechanistic Insights into the H2S-Mediated Reduction of Aryl Azides Commonly Used in H2S Detection. J Am Chem Soc (2015) 0.87
Sulfide Intoxication-Induced Circulatory Failure is Mediated by a Depression in Cardiac Contractility. Cardiovasc Toxicol (2016) 0.87
H2S during circulatory shock: some unresolved questions. Nitric Oxide (2014) 0.86
A novel persulfide detection method reveals protein persulfide- and polysulfide-reducing functions of thioredoxin and glutathione systems. Sci Adv (2016) 0.85
Selective detection of endogenous H₂S in living cells and the mouse hippocampus using a ratiometric fluorescent probe. Sci Rep (2014) 0.85
Hydrogen sulfide and polysulfides as signaling molecules. Proc Jpn Acad Ser B Phys Biol Sci (2015) 0.85
Thiosulfate Mediates Cytoprotective Effects of Hydrogen Sulfide Against Neuronal Ischemia. J Am Heart Assoc (2015) 0.84
Hydrogen sulfide measurement using sulfide dibimane: critical evaluation with electrospray ion trap mass spectrometry. Nitric Oxide (2014) 0.83
Metabolic turnover of hydrogen sulfide. Front Physiol (2012) 0.82
H2S induced coma and cardiogenic shock in the rat: Effects of phenothiazinium chromophores. Clin Toxicol (Phila) (2015) 0.82
Effects of infusion of human methemoglobin solution following hydrogen sulfide poisoning. Clin Toxicol (Phila) (2015) 0.81
Production of hydrogen sulfide from d-cysteine and its therapeutic potential. Front Endocrinol (Lausanne) (2013) 0.80
Measurement of H2S in vivo and in vitro by the monobromobimane method. Methods Enzymol (2015) 0.79
Cytoprotective effects of hydrogen sulfide-releasing N-methyl-D-aspartate receptor antagonists are mediated by intracellular sulfane sulfur. Medchemcomm (2014) 0.79
Working with nitric oxide and hydrogen sulfide in biological systems. Am J Physiol Lung Cell Mol Physiol (2014) 0.79
Hydrogen sulfide deactivates common nitrobenzofurazan-based fluorescent thiol labeling reagents. Anal Chem (2014) 0.79
Hydrogen Sulfide: A Therapeutic Candidate for Fibrotic Disease? Oxid Med Cell Longev (2015) 0.79
"Zipped Synthesis" by Cross-Metathesis Provides a Cystathionine β-Synthase Inhibitor that Attenuates Cellular H2S Levels and Reduces Neuronal Infarction in a Rat Ischemic Stroke Model. ACS Cent Sci (2016) 0.77
Emerging role of hydrogen sulfide-microRNA crosstalk in cardiovascular diseases. Am J Physiol Heart Circ Physiol (2016) 0.77
Methylene blue counteracts H2S toxicity-induced cardiac depression by restoring L-type Ca channel activity. Am J Physiol Regul Integr Comp Physiol (2016) 0.77
Developing effective countermeasures against acute hydrogen sulfide intoxication: challenges and limitations. Ann N Y Acad Sci (2016) 0.76
Is exogenous hydrogen sulfide a relevant tool to address physiological questions on hydrogen sulfide? Respir Physiol Neurobiol (2016) 0.76
Inhaled hydrogen sulfide prevents neuropathic pain after peripheral nerve injury in mice. Nitric Oxide (2014) 0.75
Phosphorylation of BK channels modulates the sensitivity to hydrogen sulfide (H2S). Front Physiol (2014) 0.75
H2S concentrations in the heart after acute H2S administration: methodological and physiological considerations. Am J Physiol Heart Circ Physiol (2016) 0.75
Sodium Hydrosulphide alleviates remote lung injury following limb traumatic injury in rats. PLoS One (2013) 0.75
New method for quantification of gasotransmitter hydrogen sulfide in biological matrices by LC-MS/MS. Sci Rep (2017) 0.75
H2S- and NO-Signaling Pathways in Alzheimer's Amyloid Vasculopathy: Synergism or Antagonism? Front Physiol (2015) 0.75
International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H2S Levels: H2S Donors and H2S Biosynthesis Inhibitors. Pharmacol Rev (2017) 0.75
Advances in the Diagnosis of Sepsis: Hydrogen Sulfide as a Prognostic Marker of Septic Shock Severity. EJIFCC (2017) 0.75
Effects of Glycyrrhetinic Acid on GSH Synthesis Induced by Realgar in the Mouse Hippocampus: Involvement of System [Formula: see text], System [Formula: see text], MRP-1, and Nrf2. Mol Neurobiol (2016) 0.75
Chemical trapping and characterization of small oxoacids of sulfur (SOS) generated in aqueous oxidations of H2S. Redox Biol (2017) 0.75
The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J (2001) 7.97
H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science (2008) 7.89
Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov (2007) 6.28
Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci U S A (2007) 5.36
H2S signals through protein S-sulfhydration. Sci Signal (2009) 4.54
Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat. Biochem J (1982) 3.76
Toxicology of hydrogen sulfide. Annu Rev Pharmacol Toxicol (1992) 3.05
Whole tissue hydrogen sulfide concentrations are orders of magnitude lower than presently accepted values. Am J Physiol Regul Integr Comp Physiol (2008) 2.78
Hydrogen sulfide mediates the vasoactivity of garlic. Proc Natl Acad Sci U S A (2007) 2.77
Analysis of biological thiols: derivatization with monobromobimane and separation by reverse-phase high-performance liquid chromatography. Anal Biochem (1981) 2.57
The gasotransmitter role of hydrogen sulfide. Antioxid Redox Signal (2003) 2.51
Trafficking in persulfides: delivering sulfur in biosynthetic pathways. Nat Chem Biol (2006) 2.43
Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: role of antioxidant and antiapoptotic signaling. Am J Physiol Heart Circ Physiol (2008) 2.19
Role of hydrogen sulphide in haemorrhagic shock in the rat: protective effect of inhibitors of hydrogen sulphide biosynthesis. Br J Pharmacol (2004) 2.09
The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver. Gastroenterology (2006) 2.08
Reappraisal of H2S/sulfide concentration in vertebrate blood and its potential significance in ischemic preconditioning and vascular signaling. Am J Physiol Regul Integr Comp Physiol (2008) 2.05
Polarographic measurement of hydrogen sulfide production and consumption by mammalian tissues. Anal Biochem (2005) 1.97
Hydrogen sulfide and its possible roles in myocardial ischemia in experimental rats. J Appl Physiol (1985) (2006) 1.84
Putative biological roles of hydrogen sulfide in health and disease: a breath of not so fresh air? Trends Pharmacol Sci (2008) 1.84
The effects of therapeutic sulfide on myocardial apoptosis in response to ischemia-reperfusion injury. Eur J Cardiothorac Surg (2008) 1.68
Hydrogen sulfide enhances ulcer healing in rats. FASEB J (2007) 1.61
Hydrogen sulfide-releasing anti-inflammatory drugs. Trends Pharmacol Sci (2007) 1.59
Analysis of biological thiols: quantitative determination of thiols at the picomole level based upon derivatization with monobromobimanes and separation by cation-exchange chromatography. Anal Biochem (1981) 1.58
Assay methods and biological roles of labile sulfur in animal tissues. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 1.48
Hydrogen sulfide mediates vasoactivity in an O2-dependent manner. Am J Physiol Heart Circ Physiol (2007) 1.45
Protective effect of hydrogen sulfide in a murine model of acute lung injury induced by combined burn and smoke inhalation. Clin Sci (Lond) (2008) 1.27
Hemodynamic and metabolic effects of hydrogen sulfide during porcine ischemia/reperfusion injury. Shock (2008) 1.26
Hydrogen sulfide decreases adenosine triphosphate levels in aortic rings and leads to vasorelaxation via metabolic inhibition. Life Sci (2008) 1.06
Beneficial effect of a hydrogen sulphide donor (sodium sulphide) in an ovine model of burn- and smoke-induced acute lung injury. Br J Pharmacol (2009) 1.03
Hydrogen sulfide regulates lung tissue-oxidized glutathione and total antioxidant capacity in hypoxic pulmonary hypertensive rats. Acta Pharmacol Sin (2008) 1.02
Treatment with H2S-releasing diclofenac protects mice against acute pancreatitis-associated lung injury. Shock (2008) 1.00
The hydrogen sulphide-releasing derivative of diclofenac protects against ischaemia-reperfusion injury in the isolated rabbit heart. Br J Pharmacol (2007) 1.00
Detection of exhaled hydrogen sulphide gas in rats exposed to intravenous sodium sulphide. Br J Pharmacol (2009) 0.99
Sulfide concentrations in postmortem mammalian tissues. J Forensic Sci (1990) 0.97
High performance liquid chromatographic determination of bound sulfide and sulfite and thiosulfate at their low levels in human serum by pre-column fluorescence derivatization with monobromobimane. Chem Pharm Bull (Tokyo) (1992) 0.93
Determination of bound sulfur in serum by gas dialysis/high-performance liquid chromatography. Anal Biochem (1993) 0.91
Sulfide consumption by mussel gill mitochondria is not strictly tied to oxygen reduction: measurements using a novel polarographic sulfide sensor. J Exp Biol (2004) 0.87
Determination of thiosulfate in body fluids by GC and GC/MS. J Anal Toxicol (1991) 0.81
Extractive alkylation and gas chromatographic analysis of sulfide. J Forensic Sci (1988) 0.79
An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature (2005) 22.40
A small molecule-kinase interaction map for clinical kinase inhibitors. Nat Biotechnol (2005) 12.22
A double-blind, delayed-start trial of rasagiline in Parkinson's disease. N Engl J Med (2009) 5.81
Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci U S A (2007) 5.36
Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J Clin Invest (2005) 4.14
LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell (2011) 3.78
Epistasis analysis with global transcriptional phenotypes. Nat Genet (2005) 2.67
Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation. Proc Natl Acad Sci U S A (2012) 2.28
Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease. Am J Pathol (2008) 2.15
Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer. J Med Chem (2004) 2.05
Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function. Proc Natl Acad Sci U S A (2011) 1.82
Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis. Ann Neurol (2002) 1.71
The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24. J Immunol (2002) 1.69
The effects of therapeutic sulfide on myocardial apoptosis in response to ischemia-reperfusion injury. Eur J Cardiothorac Surg (2008) 1.68
Therapeutic applications of PARP inhibitors: anticancer therapy and beyond. Mol Aspects Med (2013) 1.62
Inhibition of neuronal nitric oxide synthase in ovine model of acute lung injury. Crit Care Med (2009) 1.57
Selectivity of commonly used pharmacological inhibitors for cystathionine β synthase (CBS) and cystathionine γ lyase (CSE). Br J Pharmacol (2013) 1.56
Anti-inflammatory adjuvant in resuscitation fluids improves survival in hemorrhage. Crit Care Med (2009) 1.51
Therapeutic injection of PARP inhibitor INO-1001 preserves cardiac function in porcine myocardial ischemia and reperfusion without reducing infarct size. Shock (2010) 1.44
Intramitochondrial hydrogen sulfide production by 3-mercaptopyruvate sulfurtransferase maintains mitochondrial electron flow and supports cellular bioenergetics. FASEB J (2012) 1.44
Nebulized nitric oxide/nucleophile adduct reduces pulmonary vascular resistance in mechanically ventilated septicemic sheep. Crit Care Med (2005) 1.40
Effect of poly(ADP ribose) synthetase inhibition on burn and smoke inhalation injury in sheep. Am J Physiol Lung Cell Mol Physiol (2003) 1.32
Hydrogen sulfide therapy attenuates the inflammatory response in a porcine model of myocardial ischemia/reperfusion injury. J Thorac Cardiovasc Surg (2009) 1.27
Protective effect of hydrogen sulfide in a murine model of acute lung injury induced by combined burn and smoke inhalation. Clin Sci (Lond) (2008) 1.27
Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair-deficient malignant glioma xenograft. Mol Cancer Ther (2005) 1.23
Alpha7 cholinergic-agonist prevents systemic inflammation and improves survival during resuscitation. J Cell Mol Med (2008) 1.22
Detection of exhaled hydrogen sulphide gas in healthy human volunteers during intravenous administration of sodium sulphide. Br J Clin Pharmacol (2010) 1.18
The therapeutic potential of cystathionine β-synthetase/hydrogen sulfide inhibition in cancer. Antioxid Redox Signal (2014) 1.17
Effect of hydrogen sulfide in a porcine model of myocardial ischemia-reperfusion: comparison of different administration regimens and characterization of the cellular mechanisms of protection. J Cardiovasc Pharmacol (2009) 1.11
Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part II. Pathophysiological and therapeutic aspects. Br J Pharmacol (2014) 1.10
Poly (ADP-ribose) polymerase-1 is a key mediator of liver inflammation and fibrosis. Hepatology (2014) 1.09
Decrease of the inflammatory response and induction of the Akt/protein kinase B pathway by poly-(ADP-ribose) polymerase 1 inhibitor in endotoxin-induced septic shock. Biochem Pharmacol (2003) 1.05
Beneficial effect of a hydrogen sulphide donor (sodium sulphide) in an ovine model of burn- and smoke-induced acute lung injury. Br J Pharmacol (2009) 1.03
gamma-Tocopherol nebulization by a lipid aerosolization device improves pulmonary function in sheep with burn and smoke inhalation injury. Free Radic Biol Med (2008) 1.02
Poly(ADP-ribose) polymerase inhibition improves postischemic myocardial function after cardioplegia-cardiopulmonary bypass. J Am Coll Surg (2003) 1.01
Critical role of reactive nitrogen species in lung ischemia-reperfusion injury. J Heart Lung Transplant (2003) 1.00
Cellular bioenergetics is regulated by PARP1 under resting conditions and during oxidative stress. Biochem Pharmacol (2011) 1.00
Detection of exhaled hydrogen sulphide gas in rats exposed to intravenous sodium sulphide. Br J Pharmacol (2009) 0.99
Thioglycine and L-thiovaline: biologically active H₂S-donors. Bioorg Med Chem (2012) 0.97
Molecular biological effects of selective neuronal nitric oxide synthase inhibition in ovine lung injury. Am J Physiol Lung Cell Mol Physiol (2009) 0.97
Neuronal nitric oxide synthase inhibition attenuates cardiopulmonary dysfunctions after combined burn and smoke inhalation injury in sheep. Crit Care Med (2008) 0.97
Endoplasmic reticulum stress in PLP-overexpressing transgenic rats: gray matter oligodendrocytes are more vulnerable than white matter oligodendrocytes. J Neuropathol Exp Neurol (2002) 0.96
Toxicological and pathophysiological roles of reactive oxygen and nitrogen species. Toxicology (2010) 0.96
Truncated thioredoxin (Trx80) exerts unique mitogenic cytokine effects via a mechanism independent of thiol oxido-reductase activity. FEBS Lett (2003) 0.95
Indices of apoptosis activation after blood cardioplegia and cardiopulmonary bypass. Circulation (2006) 0.95
Effect of hydrogen sulfide on myocardial protection in the setting of cardioplegia and cardiopulmonary bypass. Interact Cardiovasc Thorac Surg (2010) 0.95
Coverslip hypoxia: a novel method for studying cardiac myocyte hypoxia and ischemia in vitro. Am J Physiol Heart Circ Physiol (2004) 0.95
Washout of heme-containing proteins dramatically improves tetrazolium-based infarct staining. J Pharmacol Toxicol Methods (2006) 0.93
Cell-based screening identifies paroxetine as an inhibitor of diabetic endothelial dysfunction. Diabetes (2012) 0.92
Potential role of hydrogen sulfide in the pathogenesis of vascular dysfunction in septic shock. Curr Vasc Pharmacol (2013) 0.92
Oxidative stress suppresses the cellular bioenergetic effect of the 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway. Biochem Biophys Res Commun (2013) 0.92
Hydrogen sulfide-mediated stimulation of mitochondrial electron transport involves inhibition of the mitochondrial phosphodiesterase 2A, elevation of cAMP and activation of protein kinase A. Biochem Pharmacol (2013) 0.92
Reduction of hemorrhagic transformation by PJ34, a poly(ADP-ribose)polymerase inhibitor, after permanent focal cerebral ischemia in mice. Eur J Pharmacol (2008) 0.90
Time profile of oxidative stress and neutrophil activation in ovine acute lung injury and sepsis. Shock (2012) 0.90
Deficiency in repair of the mitochondrial genome sensitizes proliferating myoblasts to oxidative damage. PLoS One (2013) 0.89
Identification of pharmacological modulators of HMGB1-induced inflammatory response by cell-based screening. PLoS One (2013) 0.89
PARP as a Drug Target for the Therapy of Diabetic Cardiovascular Dysfunction. Drug News Perspect (2002) 0.88
Effect of particulate aggregation in aquatic environments on the beam attenuation and its utility as a proxy for particulate mass. Opt Express (2009) 0.88
Nebulization with γ-tocopherol ameliorates acute lung injury after burn and smoke inhalation in the ovine model. Shock (2012) 0.88
Aging exacerbates microvascular endothelial damage induced by circulating factors present in the serum of septic patients. J Gerontol A Biol Sci Med Sci (2012) 0.88
Severe Burn Injury Induces Thermogenically Functional Mitochondria in Murine White Adipose Tissue. Shock (2015) 0.87
Recombinant human activated protein C attenuates cardiovascular and microcirculatory dysfunction in acute lung injury and septic shock. Crit Care (2010) 0.87
Poly (ADP) ribose synthetase inhibition in alveolar macrophages undergoing hypoxia and reoxygenation. Exp Mol Pathol (2007) 0.85
MafA expression and insulin promoter activity are induced by nicotinamide and related compounds in INS-1 pancreatic beta-cells. Diabetes (2006) 0.85
Hydrogen Sulfide and Cancer. Handb Exp Pharmacol (2015) 0.84
Regulation of kinase cascade activation and heat shock protein expression by poly(ADP-ribose) polymerase inhibition in doxorubicin-induced heart failure. J Cardiovasc Pharmacol (2011) 0.84
Gene expression reprogramming protects macrophage from septic-induced cell death. Mol Immunol (2010) 0.84
Intratracheal poly (ADP) ribose synthetase inhibition ameliorates lung ischemia reperfusion injury. Ann Thorac Surg (2004) 0.84
Activation of the cholinergic antiinflammatory pathway reduces ricin-induced mortality and organ failure in mice. Mol Med (2009) 0.84
Myocardial protection by PJ34, a novel potent poly (ADP-ribose) synthetase inhibitor. Ann Thorac Surg (2002) 0.83
Aerosolized linear polyethylenimine-nitric oxide/nucleophile adduct attenuates endotoxin-induced lung injury in sheep. Am J Respir Crit Care Med (2002) 0.83
Oxamyl dipeptide caspase inhibitors developed for the treatment of stroke. Bioorg Med Chem Lett (2004) 0.83
The novel inosine analogue, INO-2002, protects against diabetes development in multiple low-dose streptozotocin and non-obese diabetic mouse models of type I diabetes. J Endocrinol (2008) 0.83
Stent placement in patients with coronary heart disease decreases plasma levels of the endogenous nitric oxide synthase inhibitor ADMA. Int J Mol Med (2009) 0.82
The Flagellin-TLR5 Axis: Therapeutic Opportunities. Drug News Perspect (2002) 0.82
Influence of PARP-1 polymorphisms in patients after traumatic brain injury. J Neurotrauma (2010) 0.82
Non-clinical and clinical characterization of a novel acting thrombolytic: alfimeprase. Pathophysiol Haemost Thromb (2005) 0.82
Excessive stimulation of poly(ADP-ribosyl)ation contributes to endothelial dysfunction in pre-eclampsia. Br J Pharmacol (2005) 0.82
Enhanced peroxynitrite decomposition protects against experimental obliterative bronchiolitis. Exp Mol Pathol (2003) 0.82
Poly(ADP-ribose) polymerase-1 (PARP-1) transcriptionally regulates angiotensin AT2 receptor (AT2R) and AT2R binding protein (ATBP) genes. Biochem Pharmacol (2009) 0.82
The novel inosine analogue INO-2002 exerts an anti-inflammatory effect in a murine model of acute lung injury. Shock (2009) 0.81
Poly(adenosine diphosphate ribose) polymerase inhibition modulates spinal cord dysfunction after thoracoabdominal aortic ischemia-reperfusion. J Vasc Surg (2005) 0.81
Endotoxin tolerance: selective alterations in gene expression and protection against lymphocyte death. Immunobiology (2009) 0.80
Structure-activity relationships within a series of caspase inhibitors: effect of leaving group modifications. Bioorg Med Chem Lett (2003) 0.80
Delayed Treatment with Sodium Hydrosulfide Improves Regional Blood Flow and Alleviates Cecal Ligation and Puncture (CLP)-Induced Septic Shock. Shock (2016) 0.79
Studying ischemia and reperfusion in isolated neonatal rat ventricular myocytes using coverslip hypoxia. Methods Mol Med (2007) 0.79
Quantification of PARP activity in human tissues: ex vivo assays in blood cells and immunohistochemistry in human biopsies. Methods Mol Biol (2011) 0.79
Alfimeprase: a novel recombinant direct-acting fibrinolytic. Expert Opin Biol Ther (2006) 0.79
Assessment of inshore/offshore tributyltin pollution gradients in the northwest Portugal continental shelf using Nassarius reticulatus as a bioindicator. Environ Toxicol Chem (2006) 0.78
Bacterial lysine decarboxylase influences human dental biofilm lysine content, biofilm accumulation, and subclinical gingival inflammation. J Periodontol (2011) 0.78
Characterization of AQX-1125, a small-molecule SHIP1 activator: Part 2. Efficacy studies in allergic and pulmonary inflammation models in vivo. Br J Pharmacol (2013) 0.78